Drozitumab
Product Specifications
CAS Number
912628-39-8
Target
Apoptosis, TNF
Related Pathways
Apoptosis
Purity
0.992
Bioactivity
Drozitumab (PRO 95780) is a fully humanized antibody targeting the death receptor DR5 that shows anti-tumor activity against rhabdomyosarcoma, binds to the death receptor DR5 and induces apoptosis, and can be used in the study of triple-negative breast cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1225605 Inquire
Recombinant Verminephrobacter eiseniae DNA ligase (ligA), partial
Sign In for Pricing
View Details 586228-01 20 µg
Sal-like Protein 2, Recombinant, Human, aa1-198, Flag-Myc-Tag
Sign In for Pricing
View Details 
586228-02 100 µg
Sal-like Protein 2, Recombinant, Human, aa1-198, Flag-Myc-Tag
Sign In for Pricing
View Details 241476-01 100 mg
(R, S) -Boc-3-amino-2- (naphthalen-2-yl) -propionic acid ≥97% (HPLC)
Sign In for Pricing
View Details 241476-02 250 mg
(R, S) -Boc-3-amino-2- (naphthalen-2-yl) -propionic acid ≥97% (HPLC)
Sign In for Pricing
View Details 241476-03 1 g
(R, S) -Boc-3-amino-2- (naphthalen-2-yl) -propionic acid ≥97% (HPLC)
Sign In for Pricing
View Details